COHANCE — Cohance Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapFalling Star

Annual balance sheet for Cohance Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,898	5,279	4,859	8,234	2,858
Net Total Accounts Receivable
Net Total Receivables	1,574	2,930	1,849	2,008	3,809
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5,648	11,279	10,110	12,632	8,533
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,349	5,620	7,662	7,868	12,500
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	14,745	18,296	19,657	22,541	30,318
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,197	2,103	1,588	1,069	3,652
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	2,937	3,024	2,306	2,034	13,352
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	11,808	15,272	17,352	20,507	16,966
Total Liabilities & Shareholders' Equity	14,745	18,296	19,657	22,541	30,318
Total Common Shares Outstanding